(Q46429748)

22 December 2017

title

Rapamycin reduces VEGF expression in retinal pigment epithelium (RPE) and inhibits RPE-induced sprouting angiogenesis in vitro (English)

1 reference

22 December 2017

1 reference

A Stahl

1

1 reference

22 December 2017

L Paschek

2

1 reference

22 December 2017

G Martin

3

1 reference

22 December 2017

N J Gross

4

1 reference

22 December 2017

N Feltgen

5

1 reference

22 December 2017

L L Hansen

6

1 reference

22 December 2017

H T Agostini

7

1 reference

22 December 2017

language of work or name

English

0 references

publication date

12 August 2008

1 reference

22 December 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

FEBS Letters

1 reference

22 December 2017

volume

582

1 reference

22 December 2017

issue

20

1 reference

22 December 2017

page(s)

3097-3102

1 reference

22 December 2017

Increased expression of angiogenic growth factors in age-related maculopathy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.08.005

Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.08.005

Ranibizumab for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.08.005

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.08.005

Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.08.005

Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.08.005

Regulation of VEGF mRNA expression and protein secretion by TGF-beta2 in human retinal pigment epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.08.005

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.08.005

Signal transduction--directed cancer treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.08.005

Countervailing effects of rapamycin (sirolimus) on nuclear factor-kappa B activities in neointimal and medial smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.08.005

Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.08.005

Cultivation of retinal pigment epithelial cells from human choroidal neovascular membranes in age related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.08.005

Endothelial progenitor cell sprouting in spheroid cultures is resistant to inhibition by osteoblasts: a model for bone replacement grafts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.08.005

Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumours sensitive and resistant to anti-EGFR drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.08.005

Vascular endothelial growth factor protein levels and gene expression in peripheral monocytes after stenting: a randomized comparative study of sirolimus: eluting and bare metal stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.08.005

Insulin-like growth factor-I and its receptor in neovascular age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.08.005

Inhibition of TNF-alpha reduces laser-induced choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.08.005

Matrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.08.005

Differential expression of angioregulatory factors in normal and CNV-derived human retinal pigment epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.08.005

Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.08.005

Regulating angiogenesis at the level of PtdIns-4,5-P2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.08.005

Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.08.005

A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.08.005

The TOR pathway: a target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.08.005

10.1016/J.FEBSLET.2008.08.005

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

18703055

1 reference

22 December 2017